| Predicted proportion of patients screened given different baseline control proportions | |||||
| QI strategy | OR (95% CrI)a in patients who received QI strategyb | Order | 30% baseline screening (95% CrI) | 50% baseline screening (95% CrI) | 70% baseline screening (95% CrI) |
| CM | 1.09 (0.59 to 1.83) | Bottom | 0.32 (0.20 to 0.44) | 0.52 (0.37 to 0.65) | 0.72 (0.58 to 0.81) |
| TC | 2.01 (0.92 to 4.01) | Top | 0.46 (0.28 to 0.63) | 0.67 (0.48 to 0.80) | 0.82 (0.68 to 0.90) |
| EPR | 0.95 (0.35 to 2.42) | Bottom | 0.29 (0.13 to 0.51) | 0.49 (0.26 to 0.71) | 0.69 (0.45 to 0.85) |
| CE | 1.03 (0.75 to 1.47) | Bottom | 0.31 (0.24 to 0.39) | 0.51 (0.43 to 0.59) | 0.71 (0.64 to 0.77) |
| CR | 1.30 (0.71 to 2.57) | Middle | 0.36 (0.23 to 0.52) | 0.56 (0.41 to 0.72) | 0.75 (0.62 to 0.86) |
| FR | 0.85 (0.35 to 2.16) | Bottom | 0.27 (0.13 to 0.48) | 0.46 (0.26 to 0.68) | 0.66 (0.45 to 0.83) |
| PE | 2.32 (1.09 to 5.13) | Top | 0.50 (0.32 to 0.69) | 0.70 (0.52 to 0.84) | 0.84 (0.72 to 0.92) |
| PSM | 1.28 (0.47 to 3.42) | Middle | 0.35 (0.17 to 0.59) | 0.56 (0.32 to 0.77) | 0.75 (0.52 to 0.89) |
| PR | 1.39 (0.46 to 3.70) | Middle | 0.37 (0.16 to 0.61) | 0.58 (0.31 to 0.79) | 0.76 (0.52 to 0.90) |
| Other | 1.55 (1.04 to 2.06) | Top | 0.40 (0.31 to 0.47) | 0.61 (0.51 to 0.67) | 0.78 (0.71 to 0.83) |